1. Pink Sheet
  2. >>Geography

How Decentralized Clinical Trials Are Delivering Time And Cost Efficiencies

 
• By Vibha Sharma

A modeling study, an analysis of a dozen clinical trials and a survey of 400 clinical trial executives all show how using decentralized elements in trials can result in faster, less expensive and more engaging research.

Senior Couple Telehealth Visit
Decentralized Trials Have Drawn Much Interest Since The COVID-19 Pandemic • Source: Alamy

Using decentralized elements in clinical trials can make research faster, more efficient and patient centric, according to three new reports that add to the growing evidence supporting the use of this increasingly popular practice. 

Regulators Are Taking Step To Support DCTs

The use of wearables, telemedicine and other decentralized elements that eliminate or reduce the need for site visits by trial...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

More from Geography

UK MHRA Helps Sponsors Prepare For ‘World’s First’ Decentralized Manufacturing Framework

 
• By Neena Brizmohun

The UK drug regulator, the MHRA, is set to launch its decentralized manufacturing framework in July, and has issued a series of guidance documents that it believes will help companies and also be of value to other countries that are considering how best to regulate the fledging sector.

Argentina Speeds Up Market Access Process

 
• By Francesca Bruce

Companies operating in Argentina may get their medicines to the market more quickly thanks to new updates to the medicines authorization system.

What UK’s Clinical Trials Overhaul Means For Orphan Drug Developers

 
• By Eliza Slawther

The UK government has acknowledged that sponsors of clinical trials for rare diseases face challenges around patient recruitment and trial design, which will be addressed in its clinical trials reform, a lawyer says.